Oncology

Filter

Elacestrant Monotherapy as a Second-Line Treatment for ER-Positive, HER2-Negative Advanced Breast Cancer with ESR1 Mutations

1 Mins

December 2024

This infographic presents data from the EMERALD trial of elacestrant versus standard-of-care therapy in these patients, demonstrating that…

Elacestrant Monotherapy as a Second-Line Treatment for ER-Positive, HER2-Negative Advanced Breast Cancer with ESR1 Mutations

This infographic presents data from the EMERALD trial of elacestrant versus standard-of-care therapy in these patients, demonstrating that…

ESR1-Mutation Testing at First Progression in ER-Positive, HER2-Negative Advanced Breast Cancer

This infographic, the second in a three-part series, explores the prevalence of ESR1 mutations in patients with ER+/HER2- advanced breast…

Unmet Needs in ER+/HER2- Advanced Breast Cancer Therapy

This infographic, the first in a three-part series, explores the development of resistance to endocrine therapy in ER-Positive, HER2-Negative advanced…

Unravelling HER2+ Breast Cancer

A highly engaging infographic providing information on the incidence, diagnosis and treatment options for HER2+ breast cancer. It touches…

Cancer Vaccines

An insightful infographic summarising the latest in cancer vaccines research. Information provided summarises the prevalence of certain…

Optimising Extended Adjuvant Neratinib Use in HER2+/HR+ Early Breast Cancer: Memo For Nurses

This infographic offers valuable guidance to nurses in effectively managing neratinib patients to ensure they reap the maximum advantages…

Breakthrough Era in Endometrial Cancer Treatment: Highlights from ESMO 2023

This striking infographic provides a fascinating snapshot of the highlights in endometrial cancer research presented at the European…

Standard of Care for the Treatment of Endometrial Cancer: Change Is Afoot

Explore this infographic for insight on the current National Comprehensive Cancer Network (NCCN) guidelines on the standard of care…

Loading posts...